GHDX - Genomic Health reported EPS beat of $0.10 November, 04 2019 09:22 AM Genomic Health Inc. Genomic Health (NASDAQ:GHDX): Q3 GAAP EPS of $0.48 beats by $0.10.Revenue of $114.36M (+12.9% Y/Y) beats by $2.09M.Reported on Oct. 30, 2019.Press ReleaseMore news on: Genomic Health, Inc., Earnings news and commentary, Healthcare stocks news,